PharmaBoardroom

Cipla to Begin Manufacturing COVID-19 Drug in South Africa

The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a Covid-19 drug, in South Africa this…

China Pharma News Roundup July 24th 2020

A roundup of latest news from Chinese pharma and biotech, including a record high share price for Hansoh, strategic healthcare partnerships, venture…

Serge Kemps – CEO, Nipro Medical Europe

Serge Kemps, CEO of Nipro Medical Europe, sits down with PharmaBoardroom to shed light on Nipro’s unique corporate culture based on the Japanese…

Yeul-Hong Kim – Director, K-MASTER, South Korea

Yeul-Hong Kim, Director of K-MASTER details the project’s success in creating a shared database of genomic data for Korean oncology professionals.…

Brett Monia – CEO, Ionis Pharmaceuticals

Dr Brett Monia, co-founder and CEO of RNA therapeutics pioneer Ionis Pharmaceuticals, outlines the company’s extremely promising development…

SCM Lifescience: A Global Approach to Korean Regenerative…

Under the stewardship of regenerative medicine industry veteran BG Rhee, Korean firm SCM Lifescience has engaged in several global M&A deals in…

Key Challenges for Life Sciences & Healthcare in 2020:…

‘The Key Challenges: Life Sciences and Healthcare 2020’ is the latest report from Cornerstone International Group based on a global survey of…

Skyepharma’s David Lescuyer on Manufacturing & Supply…

David Lescuyer, managing director of fully integrated French CDMO Skyepharma, outlines how the COVID-19 crisis could usher in a new era for the…

New CEO for Ipsen as David Loew Makes Switch From Sanofi Pasteur

David Loew, formerly executive vice president of Sanofi Pasteur, Sanofi's vaccines division, was appointed CEO of fellow French firm Ipsen on the 28th…